Pathway | Size | DE fractiona | Type | Possible relation to the cancer | Reference. |
---|---|---|---|---|---|
Arachidonic acid metabolism | 50 | 34% | Lipid metabolism | Inflammation Cell growth, related to MAPK signaling pathway | |
Axon guidance | 126 | 20% | Development | Cell mobility and cell growth, related to MAPK signaling pathway | |
Nicotinate and nicotinamide metabolism | 23 | 22% | Metabolism of cofactors and vitamins | Stimulate cell growth | |
Drug metabolism - cytochrome P450 | 63 | 30% | Xenobiotics biodegradation and metabolism | Therapeutic target, related to prognosis | [75] |
Urea cycle and metabolism of amino groups | 28 | 39% | Amino acid metabolic | Nutrition intake | [76] |
Pyruvate metabolism | 41 | 37% | Carbohydrate metabolism | Nutrition intake | [76] |
Bile acid biosynthesis | 31 | 39% | Lipid metabolism | Lead to high concentration of bile acid Resistance to bile-acid induced apoptosis | |
Colorectal cancer | 84 | 15% | Disease | - | - |
Long-term depression | 70 | 15% | Disease | Unknown | - |
Amyotrophic lateral sclerosis | 54 | 15% | Disease | Inflammation and MAPK signaling pathway | - |